• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病患者下肢伤口的管理:一种分层保守方法。

Management of lower extremity wounds in patients with peripheral arterial disease: a stratified conservative approach.

作者信息

Chiriano Jason, Bianchi Christian, Teruya Theodore H, Mills Brian, Bishop Vicki, Abou-Zamzam Ahmed M

机构信息

Loma Linda VA Health Care System, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.

出版信息

Ann Vasc Surg. 2010 Nov;24(8):1110-6. doi: 10.1016/j.avsg.2010.07.012.

DOI:10.1016/j.avsg.2010.07.012
PMID:21035703
Abstract

BACKGROUND

Traditional wound care algorithms include aggressive detection of peripheral arterial disease (PAD) and treatment with revascularization for all patients with PAD and lower extremity wounds. Not every patient with PAD and a wound meets Transatlantic Inter-Society Consensus (TASCII) criteria for critical limb ischemia. We hypothesize that a conservative approach to selected patients with PAD and lower extremity wounds may be safe, provide acceptable limb salvage, and that failure of this approach does not translate into increased limb loss.

METHODS

Veterans referred with PAD and nonhealing ulcers/wounds were prospectively enrolled into our Prevention of Amputation Care Team program. Patients were stratified according to management strategies which included revascularization, primary amputation, palliative limb care, and aggressive local care without revascularization (conservative group). Patients were assigned to conservative management group on the basis of transcutaneous oxygen measurement (TcpO2) and ankle-brachial index (ABI). Healing rates, need for "late" revascularization, major amputation rates, and survival of this conservative group were analyzed in terms of ABI and ankle pressures.

RESULTS

Between January 2006 and March 2009, a total of 190 lower extremity wounds in 178 patients with PAD were analyzed. Forty-nine patients with 52 wounds (27.9%) were deemed candidates for conservative treatment. During mean follow-up of 14.5 months, complete wound healing was documented in 33 patients (35 wounds: 67%). Mean time to complete wound healing was 4.5 months. Predictors of healing included mean ABI (0.62 vs. 0.42 [p < 0.001]) and ankle pressures >70 mm Hg (p = 0.025). Sixteen patients (17 wounds: 33%) were not healed at the time of analysis. Of these, three patients (four wounds: 8%) showed active healing and 13 (13 wounds: 25%) failed conservative management. Nine patients (9 wounds: 17%) underwent late revascularization. There was one case of amputation (2%) and six cases of mortalities (12.2%). There was no increase in the rates of limb loss and mortality in patients who failed conservative management and underwent "late" revascularization.

CONCLUSIONS

Conservative management of lower extremity nonhealing wounds in selected patients with PAD is successful in over two-thirds of the patients. The failure of conservative management does not increase mortality or amputation rates. When the TcPO2 is >30 mm Hg, the ABI and the TASC II definition of critical limb ischemia predict wound healing and should be key factors in considering conservative therapy.

摘要

背景

传统的伤口护理方案包括积极检测外周动脉疾病(PAD),并对所有患有PAD和下肢伤口的患者进行血管重建治疗。并非每个患有PAD和伤口的患者都符合跨大西洋跨学会共识(TASCII)关于严重肢体缺血的标准。我们假设,对部分患有PAD和下肢伤口的患者采取保守治疗方法可能是安全的,能提供可接受的肢体挽救效果,且这种方法的失败不会导致肢体丢失增加。

方法

将患有PAD和不愈合溃疡/伤口的退伍军人前瞻性纳入我们的截肢预防护理团队项目。根据管理策略对患者进行分层,管理策略包括血管重建、一期截肢、姑息性肢体护理以及不进行血管重建的积极局部护理(保守组)。根据经皮氧分压测量(TcpO2)和踝肱指数(ABI)将患者分配到保守治疗组。根据ABI和踝部压力分析该保守组的愈合率、“晚期”血管重建的需求、大截肢率和生存率。

结果

在2006年1月至2009年3月期间,共分析了178例患有PAD的患者的190处下肢伤口。49例患者的52处伤口(27.9%)被认为适合保守治疗。在平均14.5个月的随访期间,33例患者(35处伤口:67%)实现了伤口完全愈合。伤口完全愈合的平均时间为4.5个月。愈合的预测因素包括平均ABI(0.62对0.42 [p < 0.001])和踝部压力>70 mmHg(p = 0.025)。在分析时,16例患者(17处伤口:33%)未愈合。其中,3例患者(4处伤口:8%)显示伤口正在愈合,13例(13处伤口:25%)保守治疗失败。9例患者(9处伤口:17%)接受了晚期血管重建。有1例截肢(2%)和6例死亡(12.2%)。保守治疗失败并接受“晚期”血管重建的患者的肢体丢失率和死亡率没有增加。

结论

对部分患有PAD的患者的下肢不愈合伤口进行保守治疗,超过三分之二的患者取得了成功。保守治疗失败不会增加死亡率或截肢率。当TcPO2>30 mmHg时,ABI和TASC II关于严重肢体缺血的定义可预测伤口愈合,应作为考虑保守治疗的关键因素。

相似文献

1
Management of lower extremity wounds in patients with peripheral arterial disease: a stratified conservative approach.外周动脉疾病患者下肢伤口的管理:一种分层保守方法。
Ann Vasc Surg. 2010 Nov;24(8):1110-6. doi: 10.1016/j.avsg.2010.07.012.
2
Long-Term Outcome of Patients with Peripheral Arterial Disease and Tissue Loss Stratified to a Nonrevascularization Approach.外周动脉疾病和组织缺损患者采用非血运重建方法的长期预后
Ann Vasc Surg. 2017 Feb;39:270-275. doi: 10.1016/j.avsg.2016.03.036. Epub 2016 Aug 19.
3
Early ABI Testing May Decrease Risk of Amputation for Patients With Lower Extremity Ulcers.早期踝肱指数测试可能降低下肢溃疡患者的截肢风险。
Ann Vasc Surg. 2022 Feb;79:65-71. doi: 10.1016/j.avsg.2021.08.015. Epub 2021 Oct 14.
4
Multidisciplinary approach achieves limb salvage without revascularization in patients with mild to moderate ischemia and tissue loss.多学科方法可实现轻度至中度缺血和组织丧失患者的保肢,而无需血运重建。
J Vasc Surg. 2020 Jun;71(6):2073-2080.e1. doi: 10.1016/j.jvs.2019.07.103. Epub 2019 Nov 11.
5
Prognostic factors of ulcer healing and amputation-free survival in patients with critical limb ischemia.严重肢体缺血患者溃疡愈合和无截肢生存的预后因素
Vascular. 2018 Dec;26(6):626-633. doi: 10.1177/1708538118786864. Epub 2018 Jul 13.
6
Improving limb salvage in critical ischemia with intermittent pneumatic compression: a controlled study with 18-month follow-up.间歇性气动压迫改善严重缺血肢体的挽救:一项为期18个月随访的对照研究。
J Vasc Surg. 2008 Mar;47(3):543-9. doi: 10.1016/j.jvs.2007.11.043.
7
A conservative approach to select patients with ischemic wounds is safe and effective in the setting of deferred revascularization.在延迟血运重建的情况下,对缺血性创面患者采取保守治疗方法是安全有效的。
J Vasc Surg. 2020 Apr;71(4):1286-1295. doi: 10.1016/j.jvs.2019.06.199. Epub 2020 Feb 19.
8
Analysis of wound healing time and wound-free period as outcomes after surgical and endovascular revascularization for critical lower limb ischemia.分析手术和血管内再通治疗严重下肢缺血后伤口愈合时间和无伤口期作为结局的情况。
J Vasc Surg. 2018 Mar;67(3):817-825. doi: 10.1016/j.jvs.2017.07.122. Epub 2017 Oct 9.
9
Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service.多学科截肢预防服务治疗神经缺血性伤口的结果
Ann Vasc Surg. 2015 Apr;29(3):534-42. doi: 10.1016/j.avsg.2014.10.030. Epub 2015 Jan 14.
10
Current accepted hemodynamic criteria for critical limb ischemia do not accurately stratify patients at high risk for limb loss.目前公认的严重肢体缺血的血流动力学标准并不能准确地对有肢体丧失高风险的患者进行分层。
J Vasc Surg. 2016 Jan;63(1):105-12. doi: 10.1016/j.jvs.2015.07.095. Epub 2015 Sep 26.

引用本文的文献

1
Comparison of 2-octyl cyanoacrylate and n-octyl cyanoacrylate topical skin adhesives for wound closure after ankle fracture surgery: a prospective randomized trial.2-辛基氰基丙烯酸酯和正辛基氰基丙烯酸酯局部皮肤黏合剂在踝关节骨折手术后闭合伤口的比较:一项前瞻性随机试验。
Sci Rep. 2023 Oct 10;13(1):17099. doi: 10.1038/s41598-023-43471-6.
2
Population-Based Trends in Amputations and Revascularizations for Peripheral Artery Disease From 1990 to 2009.从 1990 年到 2009 年,基于人群的外周动脉疾病截肢和血运重建趋势。
Mayo Clin Proc. 2022 May;97(5):919-930. doi: 10.1016/j.mayocp.2021.10.021. Epub 2022 Feb 15.
3
Peripheral arterial disease screening and diagnostic practice: A scoping review.
外周动脉疾病筛查和诊断实践:范围综述。
Int Wound J. 2020 Feb;17(1):32-44. doi: 10.1111/iwj.13223. Epub 2019 Nov 3.
4
Peripheral arterial disease: Scoping review of patient-centred outcomes.外周动脉疾病:以患者为中心的结局的范围综述。
Int Wound J. 2019 Dec;16(6):1521-1532. doi: 10.1111/iwj.13232. Epub 2019 Oct 9.
5
Review of the Current Management of Pressure Ulcers.压力性溃疡的当前管理综述
Adv Wound Care (New Rochelle). 2018 Feb 1;7(2):57-67. doi: 10.1089/wound.2016.0697.
6
Therapeutic Effects of Successful Angioplasty on the Aorta and Lower Limb Arteries on the Healing of Chronic Ischemic Wounds.成功的血管成形术对主动脉和下肢动脉治疗慢性缺血性伤口愈合的疗效。
J Tehran Heart Cent. 2016 Apr 13;11(2):79-84.
7
Treatment of infrapopliteal critical limb ischemia in 2013: the wound perfusion approach.2013 年治疗下肢严重肢体缺血:创面灌注方法。
Curr Cardiol Rep. 2013 Jun;15(6):363. doi: 10.1007/s11886-013-0363-5.